相关实验视频

Updated: May 31, 2025

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

一个非劣势的随机对照研究,Perampanel与Oxcarbazepine单疗治疗中风后

Cuihua Yan¹, Jing Liu², Jing Jiang³

¹Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, PR China; Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, PR China; Institute of Epilepsy, Shandong University, Jinan, Shandong, PR China; Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong, PR China; Department of Critical Care Medicine, People's Hospital of Rizhao, No. 126 Taian Road, 276827, Rizhao, PR China.

|January 23, 2025

概括

佩拉曼奈尔在治疗中风后 (PSE) 方面与牛津一样有效. 这项研究发现Perampanel的效果不劣,为治疗中风后的发作提供了可比的治疗选择.

科学领域:

神经学神经学
临床药理学临床药理学
发病学 (Epileptology) 是一个专业的学科.

背景情况:

脑卒中后 (PSE) 是一个重大的临床挑战,尽管在中风治疗方面取得了进展,但它影响了患者的治疗结果.
目前对PSE的治疗策略需要评估,特别是与已有的选择相比,新型抗发作药物 (ASM) 需要评估.

研究的目的:

为了比较Perampanel的疗效和安全性,一个新的ASM,与Oxcarbazepine,一个经典的ASM,在治疗中风后.
为了确定是否Perampanel在减少PSE患者的发作频率方面与Oxcarbazepine不劣.

主要方法:

一项前性随机对照试验,涉及2022年9月至2024年1月的67名PSE患者.
患者接受了Perampanel或Oxcarbazepine单一治疗,有效性评估为六个月后发作频率减少≥50%.
如果其有效性较低的95%置信值超过了牛巴平的发作自由率的80%,则确定了佩拉曼奈尔的非劣势性.

主要成果:

两组患者 (佩拉曼尼尔:33名患者,牛炭bazepine:34名患者) 的基线特征相似.
在六个月后,Perampanel的疗效为80.6%,而Oxcarbazepine的疗效为75.0%.
发现佩拉曼奈尔的效果不低于奥克斯卡巴兹,药物保留率和不良反应在两组之间是相似的 (P > 0.05).

结论:

佩拉曼奈尔在治疗中风后方面不逊色于奥克斯卡巴兹平.
佩拉曼奈尔代表了PSE患者的可行和有效的治疗选择,提供了可比的疗效和安全性.

关键词:

抗发作药物抗发作药物临床疗效临床疗效是一种病.氧化碳基氨酸是一种氧化碳基氨酸.佩拉曼尼尔是一种制剂.安全的安全的安全的安全的安全.

更多相关视频

Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies

Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies

Published on: October 11, 2024

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

相关概念视频

Arteries of the Lower Limbs

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...